Evidence map›Paper›PMID 33707493›Full record

ArticleScientific reports2021

An ex vivo model of medical device-mediated bacterial skin translocation.

Hao Wang, Anant Agrawal, Yi Wang, David W Crawford, Zachary D Siler, Marnie L Peterson, Ricky T Woofter, Mohamed Labib, Hainsworth Y Shin, Andrew P Baumann and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hao WangCenter for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Biology, Chemistry, and Materials Science, United States Food and Drug Administration, Silver Spring, USA.
Anant AgrawalCenter for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Biomedical Physics, United States Food and Drug Administration, Silver Spring, USA.
Yi WangCenter for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Biology, Chemistry, and Materials Science, United States Food and Drug Administration, Silver Spring, USA.
David W CrawfordPerfectus Biomed Group (Formerly Extherid Biosciences, LLC), Jackson, WY, USA.
Zachary D SilerPerfectus Biomed Group (Formerly Extherid Biosciences, LLC), Jackson, WY, USA.
Marnie L PetersonPerfectus Biomed Group (Formerly Extherid Biosciences, LLC), Jackson, WY, USA.
Ricky T WoofterLubrizol Advanced Materials, Inc., Cleveland, USA.
Mohamed LabibNovaflux Inc, Princeton, USA.
Hainsworth Y ShinCenter for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Biology, Chemistry, and Materials Science, United States Food and Drug Administration, Silver Spring, USA.
Andrew P BaumannCenter for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Applied Mechanics, United States Food and Drug Administration, Silver Spring, USA.
K Scott PhillipsCenter for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Biology, Chemistry, and Materials Science, United States Food and Drug Administration, Silver Spring, USA. kenneth.phillips@fda.hhs.gov.

Funding

Improved cleaning technology for reducing risk of transmitting infection in endoscopy.R44AI132040 · NIAID · ADVANCED BIODEVICES, LLC · PI LABIB, MOHAMED E, SOHN, SEO YEAN · 2018 to 2020
$3.0M
Improved cleaning technology for reducing risk of transmitting infection in endoscopy.R43AI132040 · NIAID · ADVANCED BIODEVICES, LLC · PI SOHN, SEO YEAN · 2017 to 2017
$286k
NIAID NIH HHS R43 AI132040NIAID NIH HHS R44 AI132040
6 · The paper itself

Abstract

The skin is a barrier and part of the immune system that protects us from harmful bacteria. Because indwelling medical devices break this barrier, they greatly increase the risk of infection by microbial pathogens. To study how these infections can be prevented through improved clinical practices and medical device technology, it is important to have preclinical models that replicate the early stages of microbial contamination, ingress, and colonization leading up to infection. At present, there are no preclinical ex vivo models specifically developed to simulate conditions for indwelling medical devices. Translocation of pathogens from outside the body across broken skin to normally sterile internal compartments is a rate-limiting step in infectious pathogenesis. In this work, we report a sensitive and reproducible ex vivo porcine skin-catheter model to test how long antimicrobial interventions can delay translocation. Skin preparation was first optimized to minimize tissue damage. The presence of skin dramatically decreased bacterial migration time across the polyurethane catheter interface from > 96 h to 12 h. Using visual colony detection, fluorescence, a luminescent in vitro imaging system, and confocal microscopy, the model was used to quantify time-dependent differences in translocation for eluting and non-eluting antimicrobial catheters. The results show the importance of including tissue in preclinical biofilm models and help to explain current gaps between in vitro testing and clinical outcomes for antimicrobial devices.

Indexed as

Bacterial TranslocationModels, BiologicalAnimalsBiofilmsCatheters, IndwellingEscherichia coliLuminescenceLuminescent ProteinsMicroscopy, FluorescenceRed Fluorescent ProteinSkinSwineLuminescent ProteinsRed Fluorescent Protein

Identifiers

PMID33707493
PMCPMC7952406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.